New needle treatment may fade melasma in darker skin
NCT ID NCT06616311
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether radiofrequency microneedling can safely treat melasma in people with darker skin tones (Fitzpatrick types IV-VI). Ten adults with melasma received the treatment, and doctors measured changes in severity using a standard scoring system. The goal was to see if this approach offers an effective option for managing melasma without long-term medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- New serums take on hydroquinone in skin brightening showdown